ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2684

Diagnosis of Systemic Diseases in Patients Presenting with Sicca Syndrome Using a Minimally-Invasive Minor Salivary Gland Biopsy: Analysis of 901 Patients

Soledad Retamozo1,2,3, Pilar Brito-Zerón1,4,5, Alejandro Alvarellos3, Veronica Saurit3, Ana C. Alvarez3, Maria Soledad Fiorentino3, Nadia Benzaquén3, Juan Pablo Pirola3, Diego Baenas3, Maria Jezabel Haye Salinas3, Albert Bove6, Isabel Sánchez-Berná7, César Morcillo8, Francisco Caeiro3 and Manuel Ramos-Casals2,5,9, 1Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, 2Sjögren Syndrome Research Group (AGAUR), Barcelona, Spain, 3Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Postgraduate Career of Rheumatology Catholic University of Córdoba, Fundación para las Ciencias Biomédicas de Córdoba (FUCIBICO), Cordoba, Argentina, 4Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain, 5Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 6Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, 7Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Institutd’Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Department of Autoimmune Diseases, ICMiD, Barcelona, Spain, 8Department of Internal Medicine, Hospital CIMA-Sanitas, Barcelona, Spain, Barcelona, Spain, 9Department of Medicine, University of Barcelona, Barcelona, Spain., Barcelona, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: SICCA, Sjogren's syndrome and biopsies

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Sjögren's Syndrome - Poster II: Clinical Science

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sicca syndrome is a clinical presentation that is common for several systemic diseases that may infiltrate the exocrine glands. The most frequent disease is Sjögren’s syndrome (SS), but other systemic diseases such as sarcoidosis, amyloidosis of IgG4-related disease may also infiltrate salivary glands. The objective was to analyze the safety and usefulness of the minimally-invasive biopsy of minor salivary glands in patients presenting with sicca syndrome suspecting a systemic disease.

Methods: We present a retrospective analysis of 901 patients presenting with sicca syndrome (xerostomia, xerophthalmia, positive ocular tests and/or parotid scintigraphy, overwhelmingly negative for anti-Ro/La antibodies) in whom a minimally-invasive biopsy of minor salivary glands was carried out between January 2005 and June 2016. All biopsy samples were obtained with the same technique and following the same study protocol, which included the evaluation of cumulative focus score of lymphoplasmacytic infiltration (Chisholm Mason score, CMs), together with investigation of granuloma, amyloid, IgG4-related disease or lipids.

Results: All biopsies but six disclosed salivary gland tissue. There are 793 (88%) women and 108 (12%) men, with a mean age of 54,46 years (range 14-86). The main histopathological diagnosis included non-specific chronic sialoadenitis (NSCS, CMs=1-2) in 429 (48%) patients, focal lymphocytic sialoadenitis diagnostic of Sjögren syndrome (FLS, CMs=3-4) in 255 (28%), normal glandular tissue (CMs=0) in 148 (16%) and chronic atrophic sialadenitis (CAS, CMs unclassifiable) in 34 (4%) patients. Other infiltrative diseases included lipoid infiltration (n=10), amyloidosis (n=4), IgG4-related disease (n=3) and sarcoidosis (n=1). The highest mean age was found in patients with CAS (66,35 years), followed by those with NSCS (54,66 years), FLS (54,04 years) and normal result (50,82 years) (p<0.001). Patients diagnosed with FLS were more frequently women (91% vs 87%, p=0.05), had a higher frequency of abnormal ocular tests (91% vs 66%, p<0.001), a higher frequency of ANA (59% vs 36%, p<0.001), RF (41% vs 18%, p<0.001), anti-Ro (28% vs 7%, p<0.001) and anti-La (11% vs 2%, p<0.001), and a higher frequency of associated autoimmune diseases (20% vs 10%, p<0.001). The percentage of patients diagnosed with SS varied according to the association or not with other autoimmune/viral diseases: 27% of patients with no associated diseases vs 34% of those with organ-specific autoimmune diseases, 42% of those with chronic viral diseases and 50% of those with other systemic autoimmune diseases (p<0.05). Abnormal ocular tests (p<0.001), ANA (p<0.001), RF (p<0.001) and anti-Ro (p<0.001) remained independent variables significantly associated with SS after adjustment by age and gender.

Conclusion: Minimally-invasive biopsy of minor salivary glands is a simple, safe, and reliable tool for the diagnosis of infiltrative systemic diseases of exocrine glands, overwhelmingly Sjögren syndrome but also amyloidosis IgG4-related disease and sarcoidosis. Lack of severe lymphocytic infiltration and atrophic histopathological data closely correlated with an older age.


Disclosure: S. Retamozo, None; P. Brito-Zerón, None; A. Alvarellos, None; V. Saurit, None; A. C. Alvarez, None; M. S. Fiorentino, None; N. Benzaquén, None; J. P. Pirola, None; D. Baenas, None; M. J. Haye Salinas, None; A. Bove, None; I. Sánchez-Berná, None; C. Morcillo, None; F. Caeiro, None; M. Ramos-Casals, None.

To cite this abstract in AMA style:

Retamozo S, Brito-Zerón P, Alvarellos A, Saurit V, Alvarez AC, Fiorentino MS, Benzaquén N, Pirola JP, Baenas D, Haye Salinas MJ, Bove A, Sánchez-Berná I, Morcillo C, Caeiro F, Ramos-Casals M. Diagnosis of Systemic Diseases in Patients Presenting with Sicca Syndrome Using a Minimally-Invasive Minor Salivary Gland Biopsy: Analysis of 901 Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/diagnosis-of-systemic-diseases-in-patients-presenting-with-sicca-syndrome-using-a-minimally-invasive-minor-salivary-gland-biopsy-analysis-of-901-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnosis-of-systemic-diseases-in-patients-presenting-with-sicca-syndrome-using-a-minimally-invasive-minor-salivary-gland-biopsy-analysis-of-901-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology